Szekacs B, Nadasy G L, Vajo Z, Juhasz I, Feher J, Monos E
2nd Clinics of Internal Medicine, Semmelweis University of Medicine, Budapest, Hungary.
Prostaglandins. 1996 Sep;52(3):221-35. doi: 10.1016/s0090-6980(96)00099-8.
The modulation of the production of prostacyclin and thromboxane from cat and cat aortic tissue slices by different vasoactive agents has been studied in order to reveal whether the release of these main two vasoactive prostanoids goes in parallel or may be controlled independently. Norepinephrine, isoproterenol, phentolamine, propranolol, angiotensin II, vasopressin, bradykinin, thrombin, verapamil, gallopamil, dopamine or methionin enkephalin were added to the incubation medium and 6-keto-PGF1 alpha (the stable metabolite of prostacyclin) and TxB2 (the stable metabolite of thromboxane) were determined in the supernatant by radioimmunoassay. The ratio of the release of prostacyclin and thromboxane was computed. Norepinephrine increased both prostacyclin and thromboxane release. Isoproterenol increased the ratio of prostacyclin and thromboxane released in cat aortic tissue slices. Phentolamine and propranolol had no effects. Angiotensin II induced a slight but statistically insignificant increase in the ratio of the two prostanoids released. Vasopressin increased thromboxane release only. Bradykinin stimulated the prostacyclin while thrombin stimulated the thromboxane release. Verapamil decreased both prostacyclin and thromboxane production. Gallopamil decreased prostacyclin release and increased thromboxane release from vessel wall slices in a certain concentration range causing a characteristic dose dependent minimum in the ratio of prostacyclin and thromboxane release. Dopamine separately increased prostacyclin release while enkephalin had no significant effect. The data obtained show that in vascular tissue some unidentified yet cytophysiological mechanisms might exist which specifically control the activities of the prostacyclin synthase and thromboxane synthase enzymes.
为了揭示这两种主要血管活性前列腺素的释放是并行的还是可以独立控制的,研究了不同血管活性剂对猫和猫主动脉组织切片中前列环素和血栓素生成的调节作用。将去甲肾上腺素、异丙肾上腺素、酚妥拉明、普萘洛尔、血管紧张素II、血管加压素、缓激肽、凝血酶、维拉帕米、加洛帕米、多巴胺或甲硫氨酸脑啡肽添加到孵育培养基中,并用放射免疫分析法测定上清液中6-酮-前列腺素F1α(前列环素的稳定代谢产物)和血栓素B2(血栓素的稳定代谢产物)。计算前列环素和血栓素的释放比率。去甲肾上腺素增加了前列环素和血栓素的释放。异丙肾上腺素增加了猫主动脉组织切片中前列环素和血栓素的释放比率。酚妥拉明和普萘洛尔没有作用。血管紧张素II使两种前列腺素释放比率略有增加,但无统计学意义。血管加压素仅增加血栓素的释放。缓激肽刺激前列环素释放,而凝血酶刺激血栓素释放。维拉帕米降低了前列环素和血栓素的生成。在一定浓度范围内,加洛帕米降低了前列环素的释放,增加了血管壁切片中血栓素的释放,导致前列环素和血栓素释放比率出现特征性的剂量依赖性最小值。多巴胺单独增加前列环素的释放,而脑啡肽没有显著作用。所获得的数据表明,在血管组织中可能存在一些尚未明确的细胞生理机制,这些机制特异性地控制前列环素合酶和血栓素合酶的活性。